Suppr超能文献

[产科疾病的抗凝治疗]

[Anticoagulant therapy in obstetrical disorders].

作者信息

Murata M, Hayakawa M, Goto K, Isobe K, Matuura T, Hirano H, Higuchi M, Maki M

机构信息

Department of Obstetrics and Gynecology, Akita University School of Medicine.

出版信息

Rinsho Ketsueki. 1990 Jun;31(6):763-8.

PMID:2170703
Abstract

Three kinds of anticoagulant therapy for obstetrical DIC were studied. 1. Antithrombin-III (AT) or gabexate mesilate for acute DIC, mainly for abruptio placentae. 2. Heparin or heparin-AT combination therapy for toxemia pregnancy. 3. Low molecular weight heparin (LMWH) for fetus of intrauterine growth retardation (IUGR). The results obtained were as follows, 1. a) Platelet count, and fibrinogen were significantly increased in AT therapy group compared with gabexate mesilate group. b) In clinical manifestation, renal failure and hemorrhagic diathesis were improved especially in AT group. 2. In heparin-AT group, high systolic blood pressure was improved during administration of AT, the high level of thrombin antithrombin complex was also found in these period. 3. a) The improvement of the gain of estimated fetal body weight was found after administration of LMWH. b) Redistribution of blood flow in one case of severe IUGR was observed during administration of LMWH.

摘要

对三种产科弥散性血管内凝血(DIC)的抗凝治疗方法进行了研究。1. 抗凝血酶III(AT)或甲磺酸加贝酯用于急性DIC,主要用于胎盘早剥。2. 肝素或肝素-AT联合治疗用于妊娠中毒症。3. 低分子量肝素(LMWH)用于宫内生长受限(IUGR)胎儿。获得的结果如下:1. a)与甲磺酸加贝酯组相比,AT治疗组的血小板计数和纤维蛋白原显著增加。b)在临床表现方面,尤其是AT组的肾衰竭和出血素质得到改善。2. 在肝素-AT组中,在给予AT期间,收缩压升高的情况得到改善,在此期间还发现凝血酶抗凝血酶复合物水平较高。3. a)给予LMWH后,估计胎儿体重增加的情况得到改善。b)在给予LMWH期间,观察到1例严重IUGR患者的血流重新分布。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验